What pharmaceutical form is Yorvipath available in?

Yorvipath: INJECTION, SOLUTION 420 ug/1.4mL (SUBCUTANEOUS)

Who manufactures Yorvipath?

Ascendis Pharma, Endocrinology, Inc.

Yorvipath: ATC H05AA02. ATC is the WHO Anatomical Therapeutic Chemical classification.

OTC

420 ug/1.4mL, Injection, solution

INN: PALOPEGTERIPARATIDE

Data updated: 2026-04-25

Saatavilla maissa:

🇨🇿🇬🇧🇯🇵🇸🇰

Muoto

INJECTION, SOLUTION

Annostus

420 ug/1.4mL

Antotapa

SUBCUTANEOUS

Säilytys

—

Tietoa tuotteesta

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.